Part I Business Overview We are a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. Our product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor (ASI) that we are developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities such as chronic kidney disease (CKD) and obstructive sleep apnea (OSA...
Q2 FY2026 — expected 2026-09-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-12 | 2025-12-31 | 0001933414-26-000056 | EDGAR | 77K words |
| 2025-02-12 | 2024-12-31 | 0001933414-25-000009 | EDGAR | — |
| 2024-03-21 | 2023-12-31 | 0001628280-24-012358 | EDGAR | — |
| 2023-03-15 | 2022-12-31 | 0001933414-23-000012 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-10 | 2025-09-30 | 0001933414-25-000142 | EDGAR | 21K words |
| 2025-08-12 | 2025-06-30 | 0001933414-25-000090 | EDGAR | — |
| 2025-05-12 | 2025-03-31 | 0001933414-25-000058 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001933414-24-000057 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0001933414-24-000039 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0001933414-24-000016 | EDGAR | — |
| 2023-11-07 | 2023-09-30 | 0001933414-23-000087 | EDGAR | — |
| 2023-08-07 | 2023-06-30 | 0001933414-23-000056 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001933414-23-000038 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-12 | 0001933414-26-000054 | EDGAR | 2K words |
| 2026-03-09 | 0001933414-26-000048 | EDGAR | — |
| 2026-01-06 | 0001933414-26-000002 | EDGAR | — |
| 2025-11-10 | 0001933414-25-000139 | EDGAR | — |
| 2025-09-03 | 0001933414-25-000120 | EDGAR | — |
| 2025-09-02 | 0001933414-25-000107 | EDGAR | — |
| 2025-08-12 | 0001933414-25-000088 | EDGAR | — |
| 2025-06-17 | 0001933414-25-000070 | EDGAR | — |
| 2025-05-22 | 0001933414-25-000064 | EDGAR | — |
| 2025-05-12 | 0001933414-25-000057 | EDGAR | — |
65 total filings indexed. 42 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001933414 |
| Ticker | MLYS |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://mineralystx.com |
| Listed | 2023-02-10 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/MLYS (~200 tokens, structured JSON with cryptographic provenance)